Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 9 CARM Carisma Therapeutics GAAP EPS of -$0.46 misses by $0.03, revenue of $3.39M misses by $1.01M
May 9 CARM Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 9 FWBI First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month
May 9 BMY Q1 2024 Editas Medicine Inc Earnings Call
May 8 APLM Apollomics Announces Private Placement Financing and Addition to Board of Directors
May 8 CARM Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024
May 8 BMY Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution
May 7 BMY A Look at Pharma ETFs Post Q1 Earnings
May 6 BMY FDA accepts Bristol Myers application for injected Opdivo
May 6 PBLA Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
May 6 CARM Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference
May 6 SABS SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
May 6 BMY U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
May 6 BMY European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
May 4 BMY Pharma R&D productivity seen improving for the first time in years - Deloitte
May 4 BMY Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago
May 3 BMY Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
May 3 BMY If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
May 3 BMY The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
May 3 BMY Bristol-Myers Squibb: A Lost Decade?
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags